AngioDynamics Net Change in Short-term Investments 2010-2025 | ANGO
AngioDynamics net change in short-term investments from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
| AngioDynamics Annual Net Change in Short-term Investments (Millions of US $) |
|
|---|---|
| 2025 | $N/A |
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $1 |
| 2018 | $N/A |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $N/A |
| 2014 | $0 |
| 2013 | $12 |
| 2012 | $70 |
| 2011 | $-44 |
| 2010 | $-42 |
| 2009 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.412B | $0.293B |
| AngioDynamics Inc. designs, manufactures and sells a wide range of medical, surgical and diagnostic devices. The devices are generally used in minimally invasive, image-guided procedures. AngioDynamics product offerings fall within three Global Business Units, namely Oncology/Surgery, Endovascular Therapies and Vascular Access. Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products and Venous Insufficiency. The Thrombus Management portfolio includes the proprietary AngioVac venous drainage cannula and circuit as well as catheter directed thrombolytic devices. Vascular Access arm offers advanced imaging equipment to guide the placement of catheters that primarily deliver short-term drug therapies. IGVA procedures include the placement of Peripherally Inserted Central Catheters lines, implantable ports and central venous catheters. Oncology/Surgery division includes Microwave Ablation, Radiofrequency Ablation and NanoKnife product lines. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.932B | 22.37 |
| Intuitive Surgical (ISRG) | United States | $169.861B | 70.41 |
| IDEXX Laboratories (IDXX) | United States | $51.765B | 53.87 |
| Edwards Lifesciences (EW) | United States | $47.690B | 31.61 |
| Alcon (ALC) | Switzerland | $39.183B | 26.31 |
| IQVIA Holdings (IQV) | United States | $32.084B | 18.13 |
| DexCom (DXCM) | United States | $29.443B | 44.17 |
| Mettler-Toledo (MTD) | United States | $26.431B | 31.37 |
| STERIS (STE) | Ireland | $24.108B | 25.66 |
| Waters (WAT) | United States | $17.717B | 24.34 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.161B | 0.00 |
| Hologic (HOLX) | United States | $14.818B | 16.05 |
| Penumbra (PEN) | United States | $10.595B | 77.40 |
| Globus Medical (GMED) | United States | $8.256B | 19.04 |
| Sysmex ADR (SSMXY) | Japan | $8.070B | 25.64 |
| Masimo (MASI) | United States | $7.657B | 25.77 |
| Teleflex (TFX) | United States | $5.578B | 9.00 |
| Glaukos (GKOS) | United States | $5.538B | 0.00 |
| TransMedics (TMDX) | United States | $3.979B | 60.48 |
| Integer Holdings (ITGR) | United States | $3.762B | 18.77 |
| LivaNova (LIVN) | United Kingdom | $3.028B | 17.33 |
| Alphatec Holdings (ATEC) | United States | $2.372B | 0.00 |
| Veracyte (VCYT) | United States | $2.356B | 32.55 |
| PROCEPT BioRobotics (PRCT) | United States | $2.244B | 0.00 |
| Artivion (AORT) | United States | $2.067B | 104.31 |
| Nihon Kohden (NHNKY) | Japan | $1.940B | 23.16 |
| Elekta AB (EKTAY) | Sweden | $1.806B | 17.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.156B | 6.62 |
| OPKO Health (OPK) | United States | $1.127B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.047B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.07 |
| Beta Bionics (BBNX) | United States | $0.813B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.797B | 0.00 |
| AxoGen (AXGN) | United States | $0.746B | 0.00 |
| SiBone (SIBN) | United States | $0.717B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.582B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.551B | 9.73 |
| OrthoPediatrics (KIDS) | United States | $0.538B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.467B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.453B | 3.64 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| RxSight (RXST) | United States | $0.374B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.371B | 9.43 |
| Spectral Diagnostics (EDTXF) | Canada | $0.305B | 0.00 |
| NeuroPace (NPCE) | United States | $0.301B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.298B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.294B | 20.26 |
| Alpha Tau Medical (DRTS) | Israel | $0.285B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.235B | 0.00 |
| Neuronetics (STIM) | United States | $0.227B | 0.00 |
| 908 Devices (MASS) | United States | $0.224B | 0.00 |
| Inogen (INGN) | United States | $0.215B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.212B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.130B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.130B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.097B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.097B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.083B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.070B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.023B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.30 |